ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
First Generic Drugs Approved in China in 2022
February 15, 2023List of the First Generic Drugs Approved in China in 2022 -
Which will be the Final Winner on the Market: Original Drugs or Generic Drugs? (2)
January 26, 2018The blood lipid regulating drugs are second only to the antineoplastic chemical drugs both on the Chinese and global markets. Statins account for about 90% share on the blood lipid regulating prescription drug market in China. -
Which will be the Final Winner on the Market: Original Drugs or Generic Drugs?
January 25, 2018The imatinib mesylate is originally developed by Novartis, and indicated for chronic myelogenous leukemia and malignant gastrointestinal stromal tumors. -
Achievements of 5 Transnational Pharmaceutical Enterprises in China!
August 28, 2017Greeting Key Nodes in the Transition in China, High-speed Growth being a Normal
Pharma Sources Insight January 2025
